| BASEC ID | Project title | Type of project | Type of clinical trial | Study phase (clinical trials only) | multi- / monocentric | Category | Principal investigator | Sponsor | Investigational sites | Lead EC | Local EC(s) | Approval date | Minors | Study Ended | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02301 | Randomized, placebo-controlled, factorial trial to assess efficacies of EMPAgliflozin and personalized dietary counseling for kidney STONE prevention in patients with recurrent calcium kidney stones | clinical trial | drugs | n/a | multicentric | B | Prof. Dr. med. Daniel Fuster | Inselspital Bern |
Inselspital, Bern University Hospital, Bern Kantonsspital Aarau, Aarau Kantonsspital Baden, Baden Universitätsspital Basel, Basel Luzerner Kantonsspital, Luzern Kantonsspital Olten, Olten Hôpitaux Uni More ... |
Kantonale Ethikkommission Bern | Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), More ... | 16.03.2026 | |||